Endpoints
Primary and Key Secondary Endpoints at 52 Weeks. The
primary endpoint (HbA1c non-inferiority) and key secondary
endpoints (change in total body weight, proportion
of patients with hypoglycaemia and proportion of patients
with weight reduction ≥5%) at 52 weeks have been previously
reported [17].